The Fanconi anemia pathway of genomic maintenance

Cellular Oncology

Volumn 28, Issue 1-2, 2006, Pages 3-29

  Levitus, Marieke ^a   Joenje, Hans ^a   De Winter, Johan P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Fanconi anemia; Genetic predisposition

Indexed keywords

BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; GENE PRODUCT; PROTEIN FANCB; PROTEIN FANCJ; PROTEIN FANCM; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; CLINICAL FEATURE; CROSS LINKING; DNA REPAIR; DNA REPLICATION ORIGIN; DRUG HYPERSENSITIVITY; FANCONI ANEMIA; GENETIC PREDISPOSITION; HUMAN; PRIORITY JOURNAL; REVIEW; UBIQUITINATION; X CHROMOSOME LINKED DISORDER;

ANIMALS; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; GENOMIC INSTABILITY; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 33646366385     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (171)

1. The Fanconi anaemia/breast cancer consortium, Positional cloning of the Fanconi anaemia group A gene, Nat. Genet. 14 (1996), 324-328.
2. Y.M. Akkari, R.L. Bateman, C.A. Reifsteck, A.D. D'Andrea, S.B. Olson and M. Grompe, The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase, Mol. Genet. Metab. 74 (2001), 403-412.
3. Y.M. Akkari, R.L. Bateman, C.A. Reifsteck, S.B. Olson and M. Grompe, DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links, Mol. Cell. Biol. 20 (2000), 8283-8289.
4. C. Allen, A. Kurimasa, M.A. Brenneman, D.J. Chen and J.A. Nickoloff, DNA-dependent protein kinase suppresses double-strand break-induced and spontaneous homologous recombination, Proc. Natl. Acad. Sci. USA 99 (2002), 3758-3763.
5. B.P. Alter, Cancer in Fanconi anemia, 1927-2001, Cancer 97 (2003), 425-440.
6. B.P. Alter, Fanconi's anemia and malignancies, Am. J. Hematol. 53 (1996), 99-110.
7. P.R. Andreassen, A.D. D'Andrea and T. Taniguchi, ATR couples FANCD2 monoubiquitination to the DNA-damage response, Genes Dev. 18 (2004), 1958-1963.
8. C. Arnaudeau, C. Lundin and T. Helleday, DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells, J. Mol. Biol. 307 (2001), 1235-1245.
9. A.D. Auerbach and R.G. Allen, Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry, Cancer Genet. Cytogenet. 51 (1991), 1-12.
10. A.D. Auerbach and S.R. Wolman, Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens, Nature 261 (1976), 494-496.
11. A.J. Bardwell, L. Bardwell, A.E. Tomkinson and E.C. Friedberg, Specific cleavage of model recombination and repair intermediates by the yeast Rad1-Rad10 DNA endonuclease, Science 265 (1994), 2082-2085.
12. G. Barnes and D. Rio, DNA double-strand-break sensitivity, DNA replication, and cell cycle arrest phenotypes of Kudeficient Saccharomyces cerevisiae, Proc. Natl. Acad. Sci. USA 94 (1997), 867-872.
13. A. Berdichevsky, L. Izhar and Z. Livneh, Error-free recombinational repair predominates over mutagenic translesion replication in E. coli, Mol. Cell. 10 (2002), 917-924.
14. T. Bessho, Induction of DNA replication-mediated double strand breaks by psoralen DNA interstrand cross-links, J. Biol. Chem. 278 (2003), 5250-5254.
15. S.B. Bigelow, J.M. Rary and M.A. Bender, G2 chromosomal radiosensitivity in Fanconi's anemia, Mutat. Res. 63 (1979), 189-199.
16. E. Blom, H.J. van de Vrugt, Y. de Vries, J.P. de Winter, F. Arwert and H. Joenje, Multiple TPR motifs characterize the Fanconi anemia FANCG protein, DNA Repair (Amst.) 3 (2004), 77-84.
17. W.L. Bridge, C.J. Vandenberg, R.J. Franklin and K. Hiom, The BACH1/BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair, Nat. Genet. 37 (2005), 953-957.
18. A. Butturini, R.P. Gale, P.C. Verlander, B. Adler-Brecher, A.P. Gillio and A.D. Auerbach, Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study, Blood 84 (1994), 1650-1655.
19. S.B. Cantor, D.W. Bell, S. Ganesan, E.M. Kass, R. Drapkin, S. Grossman, D.C. Wahrer, D.C. Sgroi, W.S. Lane, D.A. Haber and D.M. Livingston, BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function, Cell 105 (2001), 149-160.
20. S.B. Cantor, R. Drapkin, F. Zhang, Y. Lin, J. Han, S. Pamidi and D.M. Livingston, The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations, Proc. Natl. Acad. Sci. USA 101 (2004), 2357-2362.
21. M. Carreau, N. Alon, L. Bosnoyan-Collins, H. Joenje and M. Buchwald, Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups, Mutat. Res. 435 (1999), 103-109.
22. S.A. Centurion, H.R. Kuo and W.C. Lambert, Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent, Exp. Cell. Res. 260 (2000), 216-221.
23. D. Cortez, Y. Wang, I. Qin and S.J. Elledge, Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks, Science 286 (1999), 1162-1166.
24. A.D. D'Andrea and M. Grompe, Molecular biology of Fanconi anemia: Implications for diagnosis and therapy, Blood 90 (1997), 1725-1733.
25. A.A. Davies, J.Y. Masson, M.J. McIlwraith, A.Z. Stasiak, A. Stasiak, A.R. Venkitaraman and S.C. West, Role of BRCA2 in control of the RAD51 recombination and DNA repair protein, Mol. Cell. 7 (2001), 273-282.
26. W.L. de Laat, A.M. Sijbers, H. Odijk, N.G. Jaspers and J.H. Hoeijmakers, Mapping of interaction domains between human repair proteins ERCC1 and XPF, Nucleic Acids Res. 26 (1998), 4146-4152.
27. I.U. de Silva, P.J. McHugh, P.H. Clingen and J.A. Hartley, Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells, Mol. Cell. Biol. 20 (2000), 7980-7990.
28. J.P. de Winter, F. Léveillé, C.G. van Berkel, M.A. Rooimans, L. van der Weel, J. Steltenpool, I. Demuth, N.V. Morgan, N. Alon, L. Bosnoyan-Collins, J. Lightfoot, P.A. Leegwater, Q. Waisfisz, K. Komatsu, F. Arwert, J.C. Pronk, C.G. Mathew, M. Digweed, M. Buchwald and H. Joenje, Isolation of a cDNA representing the Fanconi anemia complementation group E gene, Am. J. Hum. Genet. 67 (2000), 1306-1308.
29. J.P. de Winter, M.A. Rooimans, L. van der Weel, C.G. van Berkel, N. Alon, L. Bosnoyan-Collins, J. de Groot, Y. Zhi, Q. Waisfisz, J.C. Pronk, F. Arwert, C.G. Mathew, R.J. Scheper, M.E. Hoatlin, M. Buchwald and H. Joenje, The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM, Nat. Genet. 24 (2000), 15-16.
30. J.P. de Winter, L. van der Weel, J. de Groot, S. Stone, Q. Waisfisz, F. Arwert, R.J. Scheper, F.A. Kruyt, M.E. Hoatlin and H. Joenje, The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG, Hum. Mol. Genet. 9 (2000), 2665-2674.
31. J.P. de Winter, Q. Waisfisz, M.A. Rooimans, C.G. van Berkel, L. Bosnoyan-Collins, N. Alon, M. Carreau, O. Bender, I. Demuth, D. Schindler, J.C. Pronk, F. Arwert, H. Hoehn, M. Digweed, M. Buchwald and H. Joenje, The Fanconi anaemia group G gene FANCG is identical with XRCC9, Nat. Genet. 20 (1998), 281-283.
32. M.L. Dronkert and R. Kanaar, Repair of DNA interstrand cross-links, Mutat. Res. 486 (2001), 217-247.
33. G. Duckworth-Rysiecki, K. Cornish, C.A. Clarke and M. Buchwald, Identification of two complementation groups in Fanconi anemia, Somat. Cell. Mol. Genet. 11 (1985), 35-41.
34. G. Duckworth-Rysiecki and A.M. Taylor, Effects of ionizing radiation on cells from Fanconi's anemia patients, Cancer Res. 45 (1985), 416-420.
35. P. Duesberg, R. Li, A. Fabarius and R. Hehlmann, The Chromosomal basis of cancer, Cell. Oncol. 27 (2005), 293-318.
36. B. Dutrillaux, A. Aurias, A.M. Dutrillaux, D. Buriot and M. Prieur, The cell cycle of lymphocytes in Fanconi anemia, Hum. Genet. 62 (1982), 327-332.
37. G. Fanconi, Familiaere infantile perniziösartige Anaemie (pernizioeses Blutbild und Konstitution), Jahrbuch Kinderheil 117 (1927), 257-280.
38. A. Folias, M. Matkovic, D. Bruun, S. Reid, J. Hejna, M. Grompe, A.D. D'Andrea and R. Moses, BRCA1 interacts directly with the Fanconi anemia protein FANCA, Hum. Mol. Genet. 11 (2002), 2591-2597.
39. B. Freie, X. Li, S.L. Ciccone, K. Nawa, S. Cooper, C. Vogelweid, L. Schantz, L.S. Haneline, A. Orazi, H.E. Broxmeyer, S.H. Lee and D.W. Clapp, Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis, Blood 102 (2003), 4146-4152.
40. B.W. Freie, S.L. Ciccone, X. Li, P.A. Plett, C.M. Orschell, E.F. Srour, H. Hanenberg, D. Schindler, S.H. Lee and D.W. Clapp, A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint, J. Biol. Chem. 279 (2004), 50986-50993.
41. E.C. Friedberg, DNA damage an repair, Nature 421 (2003), 436-440.
42. Y. Fujiwara, M. Tatsumi and M.S. Sasaki, Cross-link repair in human cells and its possible defect in Fanconi's anemia cells, J. Mol Biol. 113 (1977), 635-649.
43. J.C. Game, DNA double-strand breaks and the RAD50-RAD57 genes in Saccharomyces, Semin. Cancer Biol. 4 (1993), 73-83.
44. I. Garcia-Higuera and A.D. D'Andrea, Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity, Blood 93 (1999), 4025-4026.
45. I. Garcia-Higuera, Y. Kuang, J. Denham and A.D. D'Andrea, The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex, Blood 96 (2000), 3224-3230.
46. I. Garcia-Higuera, Y. Kuang, D. Naf, J. Wasik and A.D. D'Andrea, Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex, Mol. Cell. Biol. 19 (1999), 4866-4873.
47. I. Garcia-Higuera, T. Taniguchi, S. Ganesan, M.S. Meyn, C. Timmers, J. Hejna, M. Grompe and A.D. D'Andrea, Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway, Mol. Cell. 7 (2001), 249-262.
48. M. Gatei, S.P. Scott, I. Filippovitch, N. Soronika, M.F. Lavin, B. Weber and K. Khanna, Role for ATM in DNA damage-induced phosphorylation of BRCA1, Cancer Res. 60 (2000), 3299-3304.
49. M. Gatei, D. Young, K.M. Cerosaletti, A. Desai-Mehta, K. Spring, S. Kozlov, M.F. Lavin, R.A. Gatti, P. Concannon and K. Khanna, ATM-dependent phosphorylation of nibrin in response to radiation exposure, Nat. Genet. 25 (2000), 115-119.
50. B.C. Godthelp, F. Arwert, H. Joenje and M.Z. Zdzienicka, Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1, Oncogene 21 (2002), 5002-5005.
51. S.M. Gordon and M. Buchwald, Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 102 (2003), 136-141.
52. M. Gross, H. Hanenberg, S. Lobitz, R. Friedl, S. Herterich, R. Dietrich, B. Gruhn, D. Schindler and H. Hoehn, Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction, Cytogenet. Genome Res. 98 (2002), 126-135.
53. R. Gupta, S. Sharma, J.A. Sommers, Z. Jin, S.B. Cantor and R.M. Brosh, Jr., Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer, J. Biol. Chem. 280 (2005), 25450-25460.
54. T. Helleday, Pathways for mitotic homologous recombination in mammalian cells, Mutat. Res. 532 (2003), 103-115.
55. M.E. Hoatlin, T.A. Christianson, W.W. Keeble, A.T. Hammond, Y. Zhi, M.C. Heinrich, P.A. Tower and G.C. Bagby, Jr., The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells, Blood 91 (1998), 1418-1425.
56. H. Hochegger, E. Sonoda and S. Takeda, Post-replication repair in DT40 cells: translesion polymerases versus recombinases, Bioessays 26 (2004), 151-158.
57. J.H. Hong, R.A. Gatti, Y.K. Huo, C.S. Chiang and W.H. McBride, G2/M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation, Radiat. Res. 140 (1994), 17-23.
58. N.G. Howlett, T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. de Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, H. Ikeda, E.A. Fox and A.D. D'Andrea, Biallelic inactivation of BRCA2 in Fanconi anemia, Science 297 (2002), 605-609.
59. P.A. Huber, A.L. Medhurst, H. Youssoufian and C.G. Mathew, Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis, Biochem. Biophys. Res. Commun. 268 (2000), 73-77.
60. S. Hussain, J.B. Wilson, A.L. Medhurst, J. Hejna, E. Witt, S. Ananth, A. Davies, J.Y. Masson, R. Moses, S.C. West, J.P. de Winter, A. Ashworth, N.J. Jones and C.G. Mathew, Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways, Hum. Mol. Genet. 13 (2004), 1241-1248.
61. S. Hussain, E. Witt, P.A. Huber, A.L. Medhurst, A. Ashworth and C.G. Mathew, Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1, Hum. Mol. Genet. 12 (2003), 2503-2510.
62. R. Ishida and M. Buchwald, Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents, Cancer Res. 42 (1982), 4000-4006.
63. P.A. Jeggo, DNA-PK: at the cross-roads of biochemistry and genetics, Mutat. Res. 384 (1997), 1-14.
64. H. Joenje, M. Levitus, Q. Waisfisz, A.D. D'Andrea, I. Garcia-Higuera, T. Pearson, C.G. van Berkel, M.A. Rooimans, N. Morgan, C.G. Mathew and F. Arwert, Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A, Am. J. Hum. Genet. 67 (2000), 759-762.
65. H. Joenje, J.R. Lo ten Foe, A.B. Oostra, C.G. van Berkel, M.A. Rooimans, T. Schroeder-Kurth, R.D. Wegner, J.J. Gille, M. Buchwald and F. Arwert, Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype, Blood 86 (1995), 2156-2160.
66. H. Joenje, A.B. Oostra, M. Wijker, F.M. di Summa, C.G. van Berkel, M.A. Rooimans, W. Ebell, M. van Weel, J.C. Pronk, M. Buchwald and F. Arwert, Evidence for at least eight Fanconi anemia genes, Am. J. Hum. Genet. 61 (1997), 940-944.
67. H. Joenje and K.J. Patel, The emerging genetic and molecular basis of Fanconi anemia, Nat. Rev. Genet. 2 (2001), 446-457.
68. T.N. Kaiser, A. Lojewski, C. Dougherty, L. Juergens, E. Sahar and S.A. Latt, Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment, Cytometry 2 (1982), 291-297.
69. R. Kalb, M. Duerr, M. Wagner, S. Herterich, M. Gross, M. Digweed, H. Joenje, H. Hoehn and D. Schindler, Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation, Radiat. Res. 161 (2004), 318-325.
70. R. Kanaar, J.H. Hoeijmakers and D.C. van Gent, Molecular mechanisms of DNA double strand break repair, Trends Cell Biol. 8 (1998), 483-489.
71. Y. Kano and Y. Fujiwara, Roles of DNA interstrand cross-linking and its repair in the induction of sister-chromatid exchange and a higher induction in Fanconi's anemia cells, Mutat. Res. 81 (1981), 365-375.
72. K.K. Khanna and S.P. Jackson, DNA double-strand breaks: signaling, repair and the cancer connection, Nat. Genet. 27 (2001), 247-254.
73. F.A. Kruyt, F. Abou-Zahr, H. Mok and H. Youssoufian, Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain, J. Biol. Chem. 274 (1999), 34212-34218.
74. F.A. Kruyt, L.M. Dijkmans, T.K. van den Berg and H. Joenje, Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines, Blood 87 (1996), 938-948.
75. F.A. Kruyt and H. Youssoufian, The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity, Blood 92 (1998), 2229-2236.
76. Y. Kuang, I. Garcia-Higuera, A. Moran, M. Mondoux, M. Digweed and A.D. D'Andrea, Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity, Blood 96 (2000), 1625-1632.
77. M. Kubbies, D. Schindler, H. Hoehn, A. Schinzel and P.S. Rabinovitch, Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells, Am. J. Hum. Genet. 37 (1985), 1022-1030.
78. G.M. Kupfer, D. Naf, A. Suliman, M. Pulsipher and A.D. D'Andrea, The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex, Nat. Genet. 17 (1997), 487-490.
79. G.M. Kupfer, T. Yamashita, D. Naf, A. Suliman, S. Asano and A.D. D'Andrea, The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2, Blood 90 (1997), 1047-1054.
80. I. Kuraoka, W.R. Kobertz, R.R. Ariza, M. Biggerstaff, J.M. Essigmann and R.D. Wood, Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease, J. Biol. Chem. 275 (2000), 26632-26636.
81. A. Laquerbe, M. Sala-Trepat, C. Vives, M. Escarceller and D. Papadopoulo, Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients, Mutat. Res. 431 (1999), 341-350.
82. A.R. Lehmann, Replication of damaged DNA in mammalian cells: new solutions to an old problem, Mutat. Res. 509 (2002), 23-34.
83. F. Léveillé, E. Blom, A.L. Medhurst, P. Bier, E.H. Laghmani, M. Johnson, M.A. Rooimans, A. Sobeck, Q. Waisfisz, F. Arwert, K.J. Patel, M.E. Hoatlin, H. Joenje and J.P. de Winter, The Fanconi anemia gene product FANCF is a flexible adaptor protein, J. Biol. Chem. 279 (2004), 39421-39430.
84. M. Levitus, M.A. Rooimans, J. Steltenpool, N.F. Cool, A.B. Oostra, C.G. Mathew, M.E. Hoatlin, Q. Waisfisz, F. Arwert, J.P. de Winter and H. Joenje, Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes, Blood 103 (2004), 2498-2503.
85. M. Levitus, Q. Waisfisz, B.C. Godthelp, Y. de Vries, S. Hussain, W.W. Wiegant, E. Elghabzouri-Maghrani, J. Steltenpool, M.A. Rooijmans, G. Pals, F. Arwert, C.G. Mathew, M.Z. Zdzienicka, K. Hiom, J.P. de Winter and H. Joenje, The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J, Nat. Genet. 37 (2005), 934-935.
86. O. Levran, C. Attwooll, R.T. Henry, K.L. Milton, K. Neveling, P. Rio, S.D. Batish, R. Kalb, E. Velleuer, S. Barral, J. Ott, J. Petrini, D. Schindler, H. Hanenberg and A.D. Auerbach, The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia, Nat. Genet. 37 (2005), 931-933, 1296.
87. J. Lightfoot, N. Alon, L. Bosnoyan-Collins and M. Buchwald, Characterization of regions functional in the nuclear localization of the Fanconi anemia group A protein, Hum. Mol. Genet. 8 (1999), 1007-1015.
88. R. Litman, M. Peng, Z. Jin, F. Zhang, J. Zhang, S. Powell, P.R. Andreassen and S.B. Cantor, BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ, Cancer Cell. 8 (2005), 55-65.
89. J.R. Lo Ten Foe, M.A. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D.F. Callen, A. Savoia, N.C. Cheng, C.G. van Berkel, M.H. Strunk, J.J. Gille, G. Pals, P.A. Kruyt, J.C. Pronk, F. Arwert, M. Buchwald and H. Joenje, Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA, Nat. Genet. 14 (1996), 320-323.
90. L.A. Loeb, A mutator phenotype in cancer, Cancer Research 61 (2001), 3230-3239.
91. L.A. Loeb, K.R. Loeb and J.P. Anderson, Multiple mutations and cancer, Proc. Nat. Acad. Sci. USA 100 (2003), 776-781.
92. C. Lundin, K. Erixon, C. Arnaudeau, N. Schultz, D. Jenssen, M. Meuth and T. Helleday, Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells, Mol. Cell. Biol. 22 (2002), 5869-5878.
93. A.L. Medhurst, P.A. Huber, Q. Waisfisz, J.P. de Winter and C.G. Mathew, Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway, Hum. Mol. Genet. 10 (2001), 423-429.
94. A.R. Meetei, J.P. de Winter, A.L. Medhurst, M. Wallisch, Q. Waisfisz, H.J. van de Vrugt, A.B. Oostra, Z. Yan, C. Ling, C.E. Bishop, M.E. Hoatlin, H. Joenje and W. Wang, A novel ubiquitin ligase is deficient in Fanconi anemia, Nat. Genet. 35 (2003), 165-170.
95. A.R. Meetei, M. Levitus, Y. Xue, A.L. Medhurst, M. Zwaan, C. Ling, M.A. Rooimans, P. Bier, M. Hoatlin, G. Pals, J.P. de Winter, W. Wang and H. Joenje, X-linked inheritance of Fanconi anemia complementation group B, Nat. Genet. 36 (2004), 1219-1224.
96. A.R. Meetei, A.L. Medhurst, C. Ling, Y. Xue, T.R. Singh, P. Bier, J. Steltenpool, S. Stone, C.G. Mathew, I. Dokal, M. Hoatlin, H. Joenje, J.P. de Winter and W. Wang, A DNA translocase homologous to an ancient DNA repair protein is defective in Fanconi anemia, Nat. Genet. 37 (2005), 958-963.
97. A.R. Meetei, S. Sechi, M. Wallisch, D. Yang, M.K. Young, H. Joenje, M.E. Hoatlin and W. Wang, A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome, Mol. Cell. Biol. 23 (2003), 3417-3426.
98. A.R. Meetei, Z. Yan and W. Wang, FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination, Cell Cycle 3 (2004), 179-181.
99. J. Mi and G.M. Kupfer, The Fanconi anemia core complex associates with chromatin during S phase, Blood 105 (2005), 759-766.
100. B. Michel, G. Grompone, M.J. Flores and V. Bidnenko, Multiple pathways process stalled replication forks, Proc. Natl. Acad. Sci. USA 101 (2004), 12783-12788.
101. R. Montes De Oca, P.R. Andreassen, S.P. Margossian, R.G. Gregory, T. Taniguchi, X. Wang, S. Houghtaling, M. Grompe and A.D. D'Andrea, Regulated interaction of the Fanconi Anemia protein, FANCD2, with chromatin, Blood 105 (2005), 1003-1009.
102. G. Mosedale, W. Niedzwiedz, A. Alpi, F. Perrina, J.B. Pereira-Lea, M. Johnson, F. Langevin, P. Pace and K.J. Patel, The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway, Nat. Struct. Mol. Biol. 12 (2005), 763-771.
103. K. Nakanishi, T. Taniguchi, V. Ranganathan, H.V. New, L.A. Moreau, M. Stotsky, C.G. Mathew, M.B. Kastan, D.T. Weaver and A.D. D'Andrea, Interaction of FANCD2 and NBS1 in the DNA damage response, Nat. Cell. Biol. 4 (2002), 913-920.
104. K. Nakanishi, Y.G. Yang, A.J. Pierce, T. Taniguchi, M. Digweed, A.D. D'Andrea, Z.Q. Wang and M. Jasin, Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair, Proc. Natl. Acad. Sci. USA 102 (2005), 1110-1115.
105. L.J. Niedernhofer, H. Odijk, M. Budzowska, E. van Drunen, A. Maas, A.F. Theil, J. de Wit, N.G. Jaspers, H.B. Beverloo, J.H. Hoeijmakers and R. Kanaar, The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks, Mol. Cell. Biol. 24 (2004), 5776-5787.
106. L.J. Niedernhofer, A.S. Lalai and J.H.J. Hoeijmakers, Fanconi anemia (cross)linked to DNA repair, Cell 123 (2005), 1191-1198.
107. W. Niedzwiedz, G. Mosedale, M. Johnson, C.Y. Ong, P. Pace and K.J. Patel, The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair, Mol. Cell. 15 (2004), 607-620.
108. S.M. Nijman, T.T. Huang, A.M. Dirac, T.R. Brummelkamp, R.M. Kerkhoven, A.D. D'Andrea and R. Bernards, The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway, Mol. Cell. 17 (2005), 331-339.
109. A. Ohashi, M.Z. Zdzienicka, J. Chen and F.J. Couch, Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage, J. Biol. Chem. 280 (2005), 14877-14883.
110. T. Otsuki, Y. Furukawa, K. Ikeda, H. Endo, T. Yamashita, A. Shinohara, A. Iwamatsu, K. Ozawa and J.M. Liu, Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex, Hum. Mol. Genet. 10 (2001), 2651-2660.
111. P. Pace, M. Johnson, W.M. Tan, G. Mosedale, C. Sng, M.E. Hoatlin, J.P. de Winter, H. Joenje, F. Gergely and K.J. Patel, FANCE: the link between Fanconi anaemia complex assembly and activity, EMBO J. 21 (2002), 3414-3423.
112. Q. Pang, T.A. Christianson, W. Keeble, T. Koretsky and G.C. Bagby, The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC, J. Biol. Chem. 277 (2002), 49638-49643.
113. D. Papadopoulo, C. Guillouf, H. Mohrenweiser and E. Moustacchi, Hypomutability in Fanconi anemia cells is associated with increased Deletion frequency at the HPRT locus, Proc. Natl. Acad. Sci. USA 87 (1990), 8383-8387.
114. W.H. Park, S. Margossian, A.A. Horwitz, A.M. Simons, A.D. D'Andrea and J.D. Parvin, Direct DNA binding activity of the fanconi anemia D2 protein, J. Biol. Chem. 280 (2005), 23593-23598.
115. A. Pastink, J.C. Eeken and P.H. Lohman, Genomic integrity and the repair of double-strand DNA breaks, Mutat. Res. 480-481 (2001), 37-50.
116. E. Pastwa and J. Blasiak, Non-homologous DNA end joining, Acta Biochim. Pol. 50 (2003), 891-908.
117. J.H. Petrini, D.A. Bressan and M.S. Yao, The RAD52 epistasis group in mammalian double strand break repair. Semin. Immunol. 9 (1997), 181-188.
118. F.V. Rassool, DNA double strand breaks (DSB) and non-homologous end joining (NHEJ) pathways in human leukemia, Cancer Lett. 193 (2003), 1-9.
119. T. Reuter, S. Herterich, O. Bernhard, H. Hoehn and H.J. Gross, Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system, Blood 95 (2000), 719-720.
120. M.A. Risinger and J. Groden, Cross-links and crosstalk: human cancer syndromes and DNA repair defects, Cancer Cell 6 (2004), 539-545.
121. P.S. Rosenberg, M.H. Greene and B.P. Alter, Cancer incidence in persons with Fanconi anemia, Blood 101 (2003), 822-826.
122. J. Rosendorff, R. Bernstein, L. Macdougall and T. Jenkins, Fanconi anemia: another disease of unusually high prevalence in the Afrikans population of South Africa, Am. J. Med. Genet. 27 (1987), 793-797.
123. A. Rothfuss and M. Grompe, Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway, Mol. Cell. Biol. 24 (2004), 123-134.
124. M. Sala-Trepat, D. Rouillard, M. Escarceller, A. Laquerbe, E. Moustacchi and D. Papadopoulo, Arrest of S-phase progression is impaired in Fanconi anemia cells, Exp. Cell. Res. 260 (2000), 208-215.
125. A. Sancar, L.A. Lindsey-Boltz, K. Unsal-Kacmaz and S. Linn, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints, Annu. Rev. Biochem. 73 (2004), 39-85.
126. M.S. Sasaki and A. Tonomura, A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents, Cancer Res. 33 (1973), 1829-1836.
127. T.M. Schroeder, F. Anschutz and A. Knopp, Spontaneous chromosome aberrations in familial panmyelopathy, Humangenetik 1 (1964), 194-196.
128. T.M. Schroeder and J. German, Bloom's syndrome and Fanconi's anemia: demonstration of two distinctive patterns of chromosome disruption and rearrangement, Humangenetik 25 (1974), 299-306.
129. T.M. Schroeder, D. Tilgen, J. Kruger and F. Vogel, Formal genetics of Fanconi's anemia, Hum Genet. 32 (1976), 257-288.
130. S.K. Sharan and A. Bradley, Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins, J. Mammary Gland Biol. Neoplasia 3 (1998), 413-421.
131. D.S. Shin, L. Pellegrini, D.S. Daniels, B. Yelent, L. Craig, D. Bates, D.S. Yu, M.K. Shivji, C. Hitomi, A.S. Arvai, N. Volkmann, H. Tsuruta, T.L. Blundell, A.R. Venkitaraman and J.A. Tainer, Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2, EMBO J. 22 (2003), 4566-4576.
132. M.K. Shivji and A.R. Venkitaraman, DNA recombination, chromosomal stability and carcinogenesis: insights into the role of BRCA2, DNA Repair (Amst.) 3 (2004), 835-843.
133. M.A. Siddique, K. Nakanishi, T. Taniguchi, M. Grompe and A.D. D'Andrea, Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells, Exp. Hematol. 29 (2001), 1448-1455.
134. J. Smith, J.C. Andrau, S. Kallenbach, A. Laquerbe, N. Doyen and D. Papadopoulo, Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia, J. Mol. Biol. 281 (1998), 815-825.
135. D. Sridharan, M. Brown, W.C. Lambert, L.W. McMahon and M.W. Lambert, Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links, J. Cell. Sci. 116 (2003), 823-835.
136. C.A. Strathdee and M. Buchwald, Molecular and cellular biology of Fanconi anemia, Am. J. Pediatr. Hematol. Oncol. 14 (1992), 177-185.
137. C.A. Strathdee, A.M. Duncan and M. Buchwald, Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9, Nat. Genet. 1 (1992), 196-198.
138. M. Swift, Fanconi's anaemia in the genetics of neoplasia, Nature 230 (1971), 370-373.
139. T. Taniguchi and A.D. D'Andrea, Molecular pathogenesis of fanconi anemia, Int. J. Hematol. 75 (2002), 123-128.
140. T. Taniguchi and A.D. D'Andrea, The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC, Blood 100 (2002), 2457-24562.
141. T. Taniguchi, I. Garcia-Higuera, P.R. Andreassen, R.C. Gregory, M. Grompe and A.D. D'Andrea, S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51, Blood 100 (2002), 2414-2420.
142. T. Taniguchi, I. Garcia-Higuera, B. Xu, P.R. Andreassen, R.C. Gregory, S.T. Kim, W.S. Lane, M.B. Kastan and A.D. D'Andrea, Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways, Cell 109 (2002), 459-472.
143. T. Taniguchi, M. Tischkowitz, N. Ameziane, S.V. Hodgson, C.G. Mathew, H. Joenje, S.C. Mok and A.D. D'Andrea, Disruption of the Fanconi anemia-BRCA pathway in cisplatinsensitive ovarian tumors, Nat. Med. 9 (2003), 568-574.
144. L.H. Thompson, J.M. Hinz, N.A. Yamada and N.J. Jones, How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery, Environ. Mol. Mutagen. 45 (2005), 128-142.
145. C. Timmers, T. Taniguchi, J. Hejna, C. Reifsteck, L. Lucas, D. Bruun, M. Thayer, B. Cox, S. Olson, A.D. D'Andrea, R. Moses and M. Grompe, Positional cloning of a novel Fanconi anemia gene, FANCD2, Mol. Cell. 7 (2001), 241-248.
146. M.D. Tischkowitz and S.V. Hodgson, Fanconi anaemia, J. Med. Genet. 40 (2003), 1-10.
147. A. Tutt and A. Ashworth, The relationship between the roles of BRCA genes in DNA repair and cancer predisposition, Trends Mol. Med. 8 (2002), 571-576.
148. C.J. Vandenberg, F. Gergely, C.Y. Ong, P. Pace, D.L. Mallery, K. Hiom and K.J. Patel, BRCA1-independent ubiquitination of FANCD2, Mol. Cell. 12 (2003), 247-254.
149. A.R. Venkitaraman, Cancer susceptibility and the functions of BRCA1 and BRCA2, Cell 108 (2002), 171-182.
150. A.R. Venkitaraman, Tracing the network connecting BRCA and Fanconi anaemia proteins, Nat. Rev. Cancer 4 (2004), 266-276.
151. P.C. Verlander, A. Kaporis, Q. Liu, Q. Zhang, U. Seligsohn and A.D. Auerbach, Carrier frequency of the IVS4+4 A → T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population, Blood 86 (1995), 4034-4038.
152. B. Vogelstein and K.W. Kinzler, Cancer genes and the pathways they control, Nature Med. 10 (2004), 789-799.
153. B. Vogelstein and K.W. Kinzler, DNA caretaker genes, in: The Genetic Basis of Human Cancer, B. Vogelstein and K. W. Kinzler, eds, New York, 1998, pp. 317-332.
154. Q. Waisfisz, J.P. de Winter, F.A. Kruyt, J. de Groot, L. van der Weel, L.M. Dijkmans, Y. Zhi, F. Arwert, R.J. Scheper, H. Youssoufian, M.E. Hoatlin and H. Joenje, A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA, Proc. Natl. Acad. Sci. USA 96 (1999), 10320-10325.
155. Q. Waisfisz, N.V. Morgan, M. Savino, J.P. de Winter, C.G. van Berkel, M.E. Hoatlin, L. Ianzano, R.A. Gibson, F. Arwert, A. Savoia, C.G. Mathew, J.C. Pronk and H. Joenje, Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism, Nat. Genet. 22 (1999), 379-383.
156. M.P. Wajnrajch, J.M. Gertner, Z. Huma, J. Popovic, K. Lin, P.C. Verlander, S.D. Batish, P.F. Giampietro, J.G. Davis, M.I. New and A.D. Auerbach, Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry, Pediatrics 107 (2001), 744-754.
157. X. Wang and A.D. D'Andrea, The interplay of Fanconi anemia proteins in the DNA damage response, DNA Repair (Amst.) 3 (2004), 1063-1069.
158. X. Wang, P.R. Andreassen and A.D. D'Andrea, Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin, Mol. Cell. Biol. 24 (2004), 5850-5862.
159. A.J. Warren, A.E. Maccubbin and J.W. Hamilton, Detection of mitomycin C-DNA adducts in vivo by 32P-postlabeling: time course for formation and removal of adducts and biochemical modulation, Cancer Res. 58 (1998), 453-461.
160. S.T. Warren, R.A. Schultz, C.C. Chang, M.H. Wade and J.E. Trosko, Elevated spontaneous mutation rate in Bloom syndrome fibroblasts, Proc. Natl. Acad. Sci. USA 78 (1981), 3133-3137.
161. R. Weksberg, M. Buchwald, P. Sargent, M.W. Thompson and L. Siminovitch, Specific cellular defects in patients with Fanconi anemia, J. Cell. Physiol. 101 (1979), 311-323.
162. M. Whitney, M. Thayer, C. Reifsteck, S. Olson, L. Smith, P.M. Jakobs, R. Leach, S. Naylor, H. Joenje and M. Grompe, Microcell-mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p, Nat. Genet. 11 (1995), 341-343.
163. A.K. Wong, R. Pero, P.A. Ormonde, S.V. Tavtigian and P.L. Bartel, RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2, J. Biol. Chem. 272 (1997), 31941-31944.
164. B. Xu, S.T. Kim and M.B. Kastan, Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation, Mol. Cell. Biol. 21 (2001), 3445-3450.
165. T. Yamashita, D.L. Barber, Y. Zhu, N. Wu and A.D. D'Andrea, The Fanconi anemia polypeptide FACC is localized to the cytoplasm, Proc. Natl. Acad. Sci. USA 91 (1994), 6712-6716.
166. T. Yamashita, G.M. Kupfer, D. Naf, A. Suliman, H. Joenje, S. Asano and A.D. D'Andrea, The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation, Proc. Natl. Acad. Sci. USA 95 (1998), 13085-13090.
167. H. Yang, P.D. Jeffrey, J. Miller, E. Kinnucan, Y. Sun, N.H. Thoma, N. Zheng, P.L. Chen, W.H. Lee and N.P. Pavletich, BRCA2 function in DNA binding and recombination from a BRCA2-DSS 1-ssDNA structure, Science 297 (2002), 1837-1848.
168. H. Youssoufian, Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells, J. Clin. Invest. 97 (1996), 2003-2010.
169. H. Youssoufian, Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells, Proc. Natl. Acad. Sci. USA 91 (1994), 7975-7979.
170. X. Yu, C.C. Child, M. He, G. Mer and J. Chen, The BRCT domain is a phospho-protein binding domain, Science 302 (2003), 639-642.
171. N. Zhang, X. Lu, X. Zhang, C.A. Peterson and R.J. Legerski, hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro, Mol. Cell. Biol. 22 (2002), 2388-2397.